Kornitzer Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.99M Sell
59,256
-545
-0.9% -$36.3K 0.08% 226
2026
Q1
$3.76M Sell
59,801
-22,660
-27% -$1.58M 0.08% 223
2025
Q4
$5.47M Sell
82,461
-11,856
-13% -$766K 0.11% 194
2025
Q3
$6.35M Sell
94,317
-4,872
-5% -$386K 0.13% 189
2025
Q2
$8.66M Buy
99,189
+42,652
+75% +$3.34M 0.17% 149
2025
Q1
$3.86M Buy
56,537
+785
+1% +$64.1K 0.08% 250
2024
Q4
$4.34M Buy
55,752
+17,435
+46% +$1.29M 0.08% 250
2024
Q3
$2.57M Sell
38,317
-78,168
-67% -$6.42M 0.05% 303
2024
Q2
$13.2M Buy
116,485
+36,385
+45% +$4.6M 0.25% 108
2024
Q1
$11.1M Sell
80,100
-175
-0.2% -$22K 0.2% 152
2023
Q4
$9.96M Buy
+80,275
New +$8.2M 0.19% 168
2020
Q2
Sell
-253,348
Closed -$17.1M 501
2020
Q1
$17.1M Sell
253,348
-167,288
-40% -$10.4M 0.4% 79
2019
Q4
$23M Buy
+420,636
New +$20M 0.41% 88

Other funds holding DXCM

Kornitzer Capital Management's DXCM Position: Q2 2026 in Review

Kornitzer Capital Management reduced its DexCom (DXCM) stake by 0.91% in Q2 2026, selling an estimated $36.3K and leaving 59,256 shares worth $3.99M. The position accounts for 0.08% of the portfolio, ranked #226.

Kornitzer Capital Management first reported a position in DXCM in Q4 2019 and has held it in 13 quarters since. The position peaked at $23M in Q4 2019. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kornitzer Capital Management held 59,256 shares of DexCom worth $3.99M as of Q2 2026.
  • Kornitzer Capital Management sold 545 DexCom shares in Q2 2026, an estimated $36.3K.
  • DexCom made up 0.08% of Kornitzer Capital Management's portfolio in Q2 2026, its #226 holding.
  • Kornitzer Capital Management first reported a position in DexCom in Q4 2019 and has held it in 13 quarters since.
  • Kornitzer Capital Management's DexCom position peaked at $23M in Q4 2019.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.